UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 110

Sortiert nach

Poor patient-reported outcomes reporting according to CONSORT guidelines in randomized clinical trials evaluating systemic cancer therapy

Annals of oncology, 2015-01, Vol.26 (1), p.231-237

2015

Volltextzugriff (PDF)

Symptoms of Long-COVID 1-Year after a COVID-19 outbreak among sailors on a French aircraft carrier

Infectious diseases now (Online), 2023-06, Vol.53 (4), p.104673-104673, Article 104673

2023

Volltextzugriff (PDF)

Respiratory distress of unusual cause

La revue de medecine interne, 2018-11, Vol.39 (11), p.894-895

2018

Volltextzugriff (PDF)

Temporary Endobronchial Embolization with Silicone Spigots for Moderate Hemoptysis: A Retrospective Study

Respiration, 2012-01, Vol.84 (3), p.225-230

2012

Volltextzugriff (PDF)

Disseminated nocardiosis caused by Nocardia nova with brain abscesses and osteomyelitis in an immunocompetent patient

La revue de medecine interne, 2018-01, Vol.39 (1), p.57-61

2018

Volltextzugriff (PDF)

Tracheobronchomalacia in adults: breakthroughs and controversies

Revue des maladies respiratoires, 2012-12, Vol.29 (10), p.1198

2012

Volltextzugriff (PDF)

Perforation of the nasal septum: a rare complication of bevacizumab

Revue des maladies respiratoires, 2012-11, Vol.29 (9), p.1124

2012

Volltextzugriff (PDF)

Trachéobronchomalacie de l’adulte : avancées et controverses

Revue des maladies respiratoires, 2012-12, Vol.29 (10), p.1198-1208

2012

Volltextzugriff (PDF)

Perforation de la cloison nasale : une complication rare du bévacizumab

Revue des maladies respiratoires, 2012-11, Vol.29 (9), p.1124-1126

2012

Volltextzugriff (PDF)

1369P BrigAlec study: Focus on alectinib efficacy after brigatinib exposure in BrigALK2 study (GFPC 02-2019)

Annals of oncology, 2023-10, Vol.34, p.S786-S786

2023

Volltextzugriff (PDF)

Late revelation of air embolism after transthoracic needle biopsy

La revue de medecine interne, 2012-04, Vol.33 (4), p.223-226

2012

Volltextzugriff (PDF)

1035P A phase II trial of nivolumab and denosumab association as second-line treatment for stage IV non-small-cell lung cancer (NSCLC) with bone metastases: DENIVOS study (GFPC 06-2017)

Annals of oncology, 2022-09, Vol.33, p.S1028-S1029

2022

Volltextzugriff (PDF)

A phase II trial of nivolumab and denosumab association as second-line treatment for stage IV non-small-cell lung cancer (NSCLC) with bone metastases: DENIVOS study (GFPC 06-2017)

Annals of oncology, 2022-09, Vol.33 (7), p.S1028-S1029

2022

Volltextzugriff (PDF)

962P Quality of life at diagnosis for unresectable stage III NSCLC: Initial results from the national prospective study OBSTINATE (GFPC 06-2019)

Annals of oncology, 2022-09, Vol.33, p.S987

2022

Volltextzugriff (PDF)

1097P Impact of tumor and liquid rebiopsy in metastatic non-small cell lung cancer with EGFR/ALK/ROS oncogenic drivers, progressing after optimal target therapy

Annals of oncology, 2022-09, Vol.33, p.S1052-S1053

2022

Volltextzugriff (PDF)

1154P Geriatrics predictors of 3-months overall survival and chemotherapy toxicities in older patients with metastatic non-small cell lung cancer

Annals of oncology, 2022-09, Vol.33, p.S1077

2022

Volltextzugriff (PDF)

Quality of life at diagnosis for unresectable stage III NSCLC: Initial results from the national prospective study OBSTINATE (GFPC 06-2019)

Annals of oncology, 2022-09, Vol.33 (7), p.S987-S987

2022

Volltextzugriff (PDF)

Targeting the MET-Signaling Pathway in Non-Small-Cell Lung Cancer: Evidence to Date

OncoTargets and therapy, 2020-01, Vol.13, p.5691-5706

2020

Volltextzugriff (PDF)

1404P Clinical characteristics and therapeutics sequences of KRAS G12C metastatic non-small cell lung cancer (mNCSLC) patients treated by sotorasib in the French pre-marketing authorization (MA) early access program (cohort temporary authorization of use, cATU)

Annals of oncology, 2023-10, Vol.34, p.S803-S804

2023

Volltextzugriff (PDF)

LBA56 Overall survival in the KEYNOTE-671 study of perioperative pembrolizumab for early-stage non-small-cell lung cancer (NSCLC)

Annals of oncology, 2023-10, Vol.34, p.S1297-S1298

2023

Volltextzugriff (PDF)

1411TiP GFPC 06-2018: A multicenter non-randomized phase II study evaluating platinum-pemetrexed-atezolizumab (+/-bevacizumab) for patients with stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutations, ALK rearrangement or ROS1 fusion progressing after targeted therapies

Annals of oncology, 2020-09, Vol.31, p.S892-S892

2020

Volltextzugriff (PDF)

Embolie gazeuse de révélation tardive après ponction transpariétale pulmonaire

La revue de medecine interne, 2012-04, Vol.33 (4), p.223-226

2012

Volltextzugriff (PDF)

Nonoperative Management of Squamous-Cell Carcinoma of the Rectum

Diseases of the colon & rectum, 2015-01, Vol.58 (1), p.60-64

2015

Volltextzugriff (PDF)

MA14.03 Aggressiveness of Cares on the Month Before Death of Patients with Lung Cancer: A French National Database Survey

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S404-S404

2018

Volltextzugriff (PDF)

P2.15-04 Costs of Cares on the Month Before Death of Patients with Lung Cancer: A French National Database Survey

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S818-S818

2018

Volltextzugriff (PDF)

1 – 25 von 110

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(64)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences
(16)
Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Humans
(12)
Lung Cancer
(9)
Female
(8)
Cancer
(7)
Pneumologie
(7)
Sciences Biologiques Et Medicales
(7)
Sciences Medicales
(7)
Aged
(6)
Male
(6)
Bronchoscopy
(5)
Middle Aged
(5)
Respiratory System
(5)
Tumeurs De L'appareil Respiratoire Et Du Médiastin
(5)
Oncology
(4)
Adult
(3)
Cancer Pulmonaire
(3)
Epidemiology
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Poor patient-reported outcomes reporting according to CONSORT guidelines in randomized clinical trials evaluating systemic cancer therapy

Symptoms of Long-COVID 1-Year after a COVID-19 outbreak among sailors on a French aircraft carrier

Respiratory distress of unusual cause

Temporary Endobronchial Embolization with Silicone Spigots for Moderate Hemoptysis: A Retrospective Study

Disseminated nocardiosis caused by Nocardia nova with brain abscesses and osteomyelitis in an immunocompetent patient

Tracheobronchomalacia in adults: breakthroughs and controversies

Perforation of the nasal septum: a rare complication of bevacizumab

Trachéobronchomalacie de l’adulte : avancées et controverses

Perforation de la cloison nasale : une complication rare du bévacizumab

1369P BrigAlec study: Focus on alectinib efficacy after brigatinib exposure in BrigALK2 study (GFPC 02-2019)

Late revelation of air embolism after transthoracic needle biopsy

1035P A phase II trial of nivolumab and denosumab association as second-line treatment for stage IV non-small-cell lung cancer (NSCLC) with bone metastases: DENIVOS study (GFPC 06-2017)

A phase II trial of nivolumab and denosumab association as second-line treatment for stage IV non-small-cell lung cancer (NSCLC) with bone metastases: DENIVOS study (GFPC 06-2017)

962P Quality of life at diagnosis for unresectable stage III NSCLC: Initial results from the national prospective study OBSTINATE (GFPC 06-2019)

1097P Impact of tumor and liquid rebiopsy in metastatic non-small cell lung cancer with EGFR/ALK/ROS oncogenic drivers, progressing after optimal target therapy

1154P Geriatrics predictors of 3-months overall survival and chemotherapy toxicities in older patients with metastatic non-small cell lung cancer

Quality of life at diagnosis for unresectable stage III NSCLC: Initial results from the national prospective study OBSTINATE (GFPC 06-2019)

Targeting the MET-Signaling Pathway in Non-Small-Cell Lung Cancer: Evidence to Date

1404P Clinical characteristics and therapeutics sequences of KRAS G12C metastatic non-small cell lung cancer (mNCSLC) patients treated by sotorasib in the French pre-marketing authorization (MA) early access program (cohort temporary authorization of use, cATU)

LBA56 Overall survival in the KEYNOTE-671 study of perioperative pembrolizumab for early-stage non-small-cell lung cancer (NSCLC)

1411TiP GFPC 06-2018: A multicenter non-randomized phase II study evaluating platinum-pemetrexed-atezolizumab (+/-bevacizumab) for patients with stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutations, ALK rearrangement or ROS1 fusion progressing after targeted therapies

Embolie gazeuse de révélation tardive après ponction transpariétale pulmonaire

Nonoperative Management of Squamous-Cell Carcinoma of the Rectum

MA14.03 Aggressiveness of Cares on the Month Before Death of Patients with Lung Cancer: A French National Database Survey

P2.15-04 Costs of Cares on the Month Before Death of Patients with Lung Cancer: A French National Database Survey

Suchergebnisse filtern